Exceptional Q2 Masks Execution Risk on 80% Growth Target

The headline is unmistakable: HFCL delivered a quarter that looks exceptional on every line. Revenue scaled 144%, PAT surged 448%, and the company beat its own margin guidance by 289 basis points. The order book grew to ₹28,900 Cr, meaning four years of revenue visibility at current run-rate. But here is the tension that defines the quarter: management raised FY27 growth guidance sharply to at least 80% from a prior 40%, signaling confidence—yet on the same call, the MD withheld FY28 guidance, citing it is "too early," and grew evasive on preform supply constraints, calling them a "trade secret." The market has already factored in this caution. As of early September, the stock sat at ₹226.27—down 11.85% from its all-time high of ₹256.7—despite beating on every number. The question is not whether Q2 was strong. It was. The question is whether the company can sustain the pace through Q3-Q4, and whether the raised targets are achievable or overstated.

The operating performance was genuine. Revenue of ₹2,541.8 Cr (vs. ₹1,050.9 Cr prior year) reflects strong execution across the board. Optical fiber and cable orders from hyperscalers (who account for roughly 70% of HFCL's export book) drove the top line. Data center connectivity revenue alone hit ₹300 Cr in Q2—a meaningful ramp from near-zero. The Defense segment, still nascent, contributed as aerospace orders were confirmed. EPC (Engineering, Procurement, Construction), however, posted a loss of ₹121 Cr due to milestone delays on BharatNet projects; management expects recovery starting Q1 FY28 when BSNL's AMC approval clears. Margins expanded sharply: EBITDA margin hit 25.89%, beating the 23%+ guidance by 289 basis points. PAT margin expanded 862 basis points to 15.51%.

The upgrades: FY27 revenue guidance from 40% to 80% (confidence in order inflows). Capex from ₹640 Cr to ₹1,800 Cr, signaling a major capacity expansion bet. Defense and Connectivity targets elevated with explicit FY28-FY29 milestones (prior guidance was vague). The downgrades: EPC recovery timeline pushed from vague to explicit Q1 FY28, confirming continued near-term drag. FY28 guidance withheld entirely, signaling management is uncertain about sustaining the aggressive pace past this year.

Price and momentum: As of early September, the stock traded at ₹226.27, down 11.85% from its all-time high of ₹256.7, but well above its 52-week low of ₹59.82 (up 278% from the low). The stock is trading above its 20-, 50-, and 200-day moving averages (₹228, ₹217, ₹126 respectively), suggesting an intact uptrend, but the failure to push past the all-time high despite beating on every number is a subtle warning. RSI at 50.6 is neutral—neither overbought nor oversold—and volume is normal. Institutional flows: FII ownership surged from 7.08% in Q4 FY26 to 15.74% in Q1 FY27—an 866 basis point jump—signaling institutional confidence. DII also added, moving from 8.58% to 10.92%. Notably, bulk/block deals over the past six months show small institutional players (JUNOMONETA, HRTI, QE Securities) accumulating stock around ₹113-115—lower than the current price—with no promoter alarm or insider selling. This pattern suggests quiet institutional confidence in the near-term, but the lack of new-high penetration and the withheld FY28 guidance suggest the market is pricing in execution risk and is waiting for Q3 results before pushing higher. The takeaway: Institutions are net buyers, but at lower prices. The market has factored in that 80% FY27 guidance is aggressive and that Q3-Q4 execution will be tested.